Copyright Reports & Markets. All rights reserved.

Global Pyelonephritis Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Pyelonephritis Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Pyelonephritis Drug Market Size Growth Rate by Product
      • 1.4.2 Finafloxacin
      • 1.4.3 Fosfomycin Tromethamine
      • 1.4.4 Nacubactam
      • 1.4.5 Plazomicin Sulfate
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Pyelonephritis Drug Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Pyelonephritis Drug Market Size
      • 2.1.1 Global Pyelonephritis Drug Revenue 2014-2025
      • 2.1.2 Global Pyelonephritis Drug Sales 2014-2025
    • 2.2 Pyelonephritis Drug Growth Rate by Regions
      • 2.2.1 Global Pyelonephritis Drug Sales by Regions
      • 2.2.2 Global Pyelonephritis Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Pyelonephritis Drug Sales by Manufacturers
      • 3.1.1 Pyelonephritis Drug Sales by Manufacturers
      • 3.1.2 Pyelonephritis Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Pyelonephritis Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pyelonephritis Drug Revenue by Manufacturers
      • 3.2.1 Pyelonephritis Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pyelonephritis Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Pyelonephritis Drug Price by Manufacturers
    • 3.4 Pyelonephritis Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Pyelonephritis Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Pyelonephritis Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Pyelonephritis Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Pyelonephritis Drug Sales by Product
    • 4.2 Global Pyelonephritis Drug Revenue by Product
    • 4.3 Pyelonephritis Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Pyelonephritis Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Pyelonephritis Drug by Countries
      • 6.1.1 North America Pyelonephritis Drug Sales by Countries
      • 6.1.2 North America Pyelonephritis Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Pyelonephritis Drug by Product
    • 6.3 North America Pyelonephritis Drug by End User

    7 Europe

    • 7.1 Europe Pyelonephritis Drug by Countries
      • 7.1.1 Europe Pyelonephritis Drug Sales by Countries
      • 7.1.2 Europe Pyelonephritis Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Pyelonephritis Drug by Product
    • 7.3 Europe Pyelonephritis Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Pyelonephritis Drug by Countries
      • 8.1.1 Asia Pacific Pyelonephritis Drug Sales by Countries
      • 8.1.2 Asia Pacific Pyelonephritis Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Pyelonephritis Drug by Product
    • 8.3 Asia Pacific Pyelonephritis Drug by End User

    9 Central & South America

    • 9.1 Central & South America Pyelonephritis Drug by Countries
      • 9.1.1 Central & South America Pyelonephritis Drug Sales by Countries
      • 9.1.2 Central & South America Pyelonephritis Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Pyelonephritis Drug by Product
    • 9.3 Central & South America Pyelonephritis Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Pyelonephritis Drug by Countries
      • 10.1.1 Middle East and Africa Pyelonephritis Drug Sales by Countries
      • 10.1.2 Middle East and Africa Pyelonephritis Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Pyelonephritis Drug by Product
    • 10.3 Middle East and Africa Pyelonephritis Drug by End User

    11 Company Profiles

    • 11.1 Achaogen Inc
      • 11.1.1 Achaogen Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Achaogen Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Achaogen Inc Pyelonephritis Drug Products Offered
      • 11.1.5 Achaogen Inc Recent Development
    • 11.2 AstraZeneca Plc
      • 11.2.1 AstraZeneca Plc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 AstraZeneca Plc Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 AstraZeneca Plc Pyelonephritis Drug Products Offered
      • 11.2.5 AstraZeneca Plc Recent Development
    • 11.3 Meiji Seika Pharma Co Ltd
      • 11.3.1 Meiji Seika Pharma Co Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Products Offered
      • 11.3.5 Meiji Seika Pharma Co Ltd Recent Development
    • 11.4 Merck & Co Inc
      • 11.4.1 Merck & Co Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck & Co Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck & Co Inc Pyelonephritis Drug Products Offered
      • 11.4.5 Merck & Co Inc Recent Development
    • 11.5 MerLion Pharmaceuticals Pte Ltd
      • 11.5.1 MerLion Pharmaceuticals Pte Ltd Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Products Offered
      • 11.5.5 MerLion Pharmaceuticals Pte Ltd Recent Development
    • 11.6 The Medicines Company
      • 11.6.1 The Medicines Company Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 The Medicines Company Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 The Medicines Company Pyelonephritis Drug Products Offered
      • 11.6.5 The Medicines Company Recent Development
    • 11.7 Zavante Therapeutics Inc
      • 11.7.1 Zavante Therapeutics Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Zavante Therapeutics Inc Pyelonephritis Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Zavante Therapeutics Inc Pyelonephritis Drug Products Offered
      • 11.7.5 Zavante Therapeutics Inc Recent Development

    12 Future Forecast

    • 12.1 Pyelonephritis Drug Market Forecast by Regions
      • 12.1.1 Global Pyelonephritis Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Pyelonephritis Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Pyelonephritis Drug Market Forecast by Product
      • 12.2.1 Global Pyelonephritis Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Pyelonephritis Drug Revenue Forecast by Product 2019-2025
    • 12.3 Pyelonephritis Drug Market Forecast by End User
    • 12.4 North America Pyelonephritis Drug Forecast
    • 12.5 Europe Pyelonephritis Drug Forecast
    • 12.6 Asia Pacific Pyelonephritis Drug Forecast
    • 12.7 Central & South America Pyelonephritis Drug Forecast
    • 12.8 Middle East and Africa Pyelonephritis Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Pyelonephritis Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Pyelonephritis Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pyelonephritis Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Pyelonephritis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pyelonephritis Drug in these regions.
      This research report categorizes the global Pyelonephritis Drug market by top players/brands, region, type and end user. This report also studies the global Pyelonephritis Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Achaogen Inc
      AstraZeneca Plc
      Meiji Seika Pharma Co Ltd
      Merck & Co Inc
      MerLion Pharmaceuticals Pte Ltd
      The Medicines Company
      Zavante Therapeutics Inc

      Market size by Product
      Finafloxacin
      Fosfomycin Tromethamine
      Nacubactam
      Plazomicin Sulfate
      Others
      Market size by End User
      Hospital
      Clinic
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Pyelonephritis Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Pyelonephritis Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Pyelonephritis Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Pyelonephritis Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Pyelonephritis Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pyelonephritis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now